Cargando…
Identification of berberine as a novel drug for the treatment of multiple myeloma via targeting UHRF1
BACKGROUND: Current therapies for multiple myeloma (MM) are associated with toxicity and resistance, highlighting the need for novel effective therapeutics. Berberine (BBR), a botanical alkaloid derived from several Berberis medicinal plants, has exhibited anti-tumor effects, including against multi...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098108/ https://www.ncbi.nlm.nih.gov/pubmed/32213189 http://dx.doi.org/10.1186/s12915-020-00766-8 |